Evaluating the Effectiveness of an AI Enhanced Mobile Application in Improving Management Outcomes for Atopic Dermatitis Patients A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- IADVL
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Change in SCORAD (Scoring Atopic Dermatitis) index from baseline to 12 weeks.
研究概览
简要总结
This research project evaluates the effectiveness of an AI-powered mobile app designed to manage atopic dermatitis over two years. We aim to test whether this app can enhance treatment adherence and patient outcomes compared to traditional care methods. Initially, the project will focus on developing the app, which will include features to monitor disease severity, provide medication reminders, and offer educational support through an integrated chatbot.
Following development, the project will conduct a 15-month randomized controlled trial involving 100 patients. The effectiveness of the app will be assessed using the SCORAD index to measure changes in disease severity, alongside evaluations of treatment adherence, quality of life improvements, and patient satisfaction. The study aims to demonstrate that digital tools can significantly improve the management and outcomes of chronic dermatological conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Diagnosed with atopic dermatitis by a dermatologist.
- •Ages 18 and above.
- •Smartphone users willing to use the app.
排除标准
- •Patients with other primary skin disorders.
- •Patients with severe atopic dermatitis requiring systemic therapy.
- •Current participation in another clinical trial.
结局指标
主要结局
Change in SCORAD (Scoring Atopic Dermatitis) index from baseline to 12 weeks.
时间窗: Change in SCORAD (Scoring Atopic Dermatitis) index from baseline to 12 weeks.
次要结局
- changes in POEM scores, changes in DLQI scores, and patient satisfaction with the AI-enabled application at 12 weeks.(12 weeks)
研究者
Neena Khanna
Amrita Hospital